Ultrasound-guided Dextrose Injection Versus Dextrose With Methylprednisolone in Carpal Tunnel Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT06045013

Recruitment Status : Recruiting

First Posted : September 21, 2023

Last Update Posted : September 21, 2023

See Contacts and Locations

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

Clinical Hospital Centre Zagreb

School of Public Health Andrija Štampar

Information provided by (Responsible Party):

Igor Begović, General and Veteran Hospital Croatian Pride Knin

Study Description

Brief Summary:

The goal of this prospective, randomized, double-blinded, head-to-head comparative study is to compare the efficacy of ultrasound-guided 4 ml 5% dextrose perineural injection versus 3 ml 5% dextrose with 1 ml 40 mg/ml methylprednisolone perineural injection in patients with carpal tunnel syndrome (CTS).

The main questions it aims to answer are:

Is there a difference in efficacy between interventions regarding 1. pain alleviation, 2. improvement in symptoms severity and functional status, 3. improvement in grip strength, 4. size of median nerve cross-sectional area, and 5. improvement in quality of life during the six-month post-intervention follow-up period?

Condition or disease	Intervention/treatment	Phase
Carpal Tunnel Syndrome	Drug: 5% dextrose injection Drug: 5% dextrose injections with methylprednisolone acetate 40 mg/ml	Phase 3

Show detailed description

Detailed Description:

The research will be conducted in the General and Veteran Hospital "Croatian Pride" Knin.

The research will be a prospective, randomized, double-blinded, head-to-head comparative study.

The goal of the research is to compare the efficacy of ultrasound-guided 5% dextrose injection versus 5% dextrose with 40 mg methylprednisolone injection in patients with carpal tunnel syndrome (CTS).

Randomization of patients will be performed before the intervention using computer software.

All participants will sign written informed consent and the study will be performed under the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study is approved by the Ethical Committee at the General and Veteran Hospital "Croatian Pride" Knin (approval number: 510.01/23-01/79).

Adult participants aged between 18 and 80 years with a clinical and electrophysiological diagnosis of idiopathic CTS referred to the Physical Medicine and Rehabilitation clinic will be randomly assigned into two groups using a random number generating software in a 1:1 manner.

Since patients can have CTS in one or both hands, randomization will be conducted according to the patient, thus the same patient can receive the intervention only on one side which will be considered worst.

The minimum sample size of a total of 70 participants (35 in each group) was estimated by analyzing the power of the t-test for independent samples according to the following characteristics: type one error (α=0.05), power (1-ß=0.80), and effect size (d=0.68).

The power analysis of the test was performed using the computer program G*Power for Windows, version 3.1.3.

IBM SPSS Statistics version 29.0 software will be used for the data analysis.

Group one will receive an ultrasound-guided 4 ml single perineural injection of 5% dextrose in the carpal tunnel and group two ultrasound-guided single perineural injection of 3 ml 5% dextrose plus 1 ml 40 mg/ml methylprednisolone acetate in the carpal tunnel.

Participants, the physician who will perform the injection procedure and the assessor will be blinded for the treatment allocation. The only person who will know which intervention drug it is about will be the nurse who will prepare the medicine according to the randomization.

Clinical diagnosis of CTS will be made in the presence of at least one symptom (1. pain, 2. pricking, 3. tingling, 4. burning, or 5. numbness in the innervation area of the median nerve on the hand) and at least one sign (1. objective disturbance of the sense of touch, i.e. hypoesthesia or dysesthesia in the innervation area of the median nerve on the hand, 2. positive Tinel's sign, 3. positive Phalen's sign, or 4. positive compression test).

Inclusion criteria are age between 18 and 80 years and the diagnosis of idiopathic CTS based on clinical and electrophysiological criteria.

Exclusion criteria are contraindications for local application of methylprednisolone or 5% dextrose (hypersensitivity to the drug, infection, and skin damage at the application site), previous wrist surgery, traumatic wrist injury within 2 years, previous wrist injection within 6 months, previous physical therapy within 6 months, history of traumatic peripheral nerve injury in the upper extremity, brachial plexopathy, severe cervical radiculopathy and thoracic outlet syndrome, history of diabetes, history of thyroid disease, history of inflammatory rheumatic disease, pregnancy and inability to cooperate with the study protocol.

Basic demographic data will be obtained: gender, age, Body Mass Index (BMI), level of education, occupation, rating of hand activity and force level applied on the hand during the day, cigarette smoking, hand dominance, affected hand, symptom duration, and history of comorbid conditions.

Pain intensity (using a 10 cm Visual Analogue Scale; VAS pain, 0-10; 0=no pain, 10=the most severe pain), symptoms severity and functional impairment (using the Boston Carpal Tunnel Questionnaire; BCTQ), grip strength (using the Jamar hydraulic hand dynamometer in kilograms), median nerve cross-sectional area (CSA) (using diagnostic ultrasound at the carpal tunnel inlet), and quality of life (QoL) (using 36-Item Short Form Survey; SF-36) will be measured immediately before injection, at 4, 12, and 24 weeks post-injection.

The primary outcome measure will be the change in pain intensity at 4 weeks post-injection.

Secondary outcome measures will be the change in pain intensity at 12 and 24 weeks post-injection, and the changes in symptoms severity and functional impairment, grip strength, median nerve CSA, and QoL at 4, 12, and 24 weeks post-injection.

During the study, acetaminophen and tramadol will be allowed for occasional pain relief except for two days prior to the evaluation sessions due to possible interference with the results.

Physical therapy, use of wrist splints, acupuncture, and invasive interventions for CTS other than those included in the study protocol will not be allowed during the study.

Study Design

Layout table for study information

Study Type :	Interventional (Clinical Trial)
Estimated Enrollment :	70 participants
Allocation:	Randomized
Intervention Model:	Parallel Assignment
Masking:	Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:	Treatment
Official Title:	Comparison of the Efficacy Between Ultrasound-guided Dextrose Injection Versus Dextrose With Methylprednisolone Injection in Patients With Carpal Tunnel Syndrome: a Prospective, Randomized Double-blind Clinical Trial.
Actual Study Start Date :	September 13, 2023
Estimated Primary Completion Date :	January 1, 2026
Estimated Study Completion Date :	August 30, 2026

Resource links provided by the National Library of Medicine

MedlinePlus Genetics related topics: Carpal tunnel syndrome

MedlinePlus related topics: Carpal Tunnel Syndrome

Drug Information available for: Prednisolone Prednisolone acetate Methylprednisolone acetate Methylprednisolone Prednisolone sodium phosphate Prednisolone phosphate Prednisolone sodium succinate Methylprednisolone sodium succinate Dextrose

Genetic and Rare Diseases Information Center resources: Charcot-Marie-Tooth Disease Hereditary Neuropathy With Liability to Pressure Palsies Roussy Levy Syndrome

U.S. FDA Resources

Arms and Interventions

Arm	Intervention/treatment
Active Comparator: 5% dextrose injection Ultrasound-guided 4 ml single injection of 5% dextrose	Drug: 5% dextrose injection Single ultrasound-guided injection of 4 ml 5% dextrose in carpal tunnel via ulnar approach. Other Name: 5% dextrose
Active Comparator: 5% dextrose injections with methylprednisolone acetate Ultrasound-guided single injection of 3 ml 5% dextrose plus 1 ml 40 mg/ml methylprednisolone acetate	Drug: 5% dextrose injections with methylprednisolone acetate 40 mg/ml Single ultrasound-guided injection of 3 ml 5% dextrose with 1 ml 40 mg/ml methylprednisolone acetate in carpal tunnel via ulnar approach. Other Name: Depo-Medrol 40 mg/ml

Outcome Measures

Primary Outcome Measures :

Pain intensity at 4 weeks post injection [ Time Frame: before injection, 4 weeks post injection ]
Assessment of pain intensity using 10 cm Visual Analogue Scale (VAS pain), 0-10; 0=no pain, 10=the most severe pain.

Secondary Outcome Measures :

Pain intensity at 12 and 24 weeks post injection [ Time Frame: before injection,12 and 24 weeks post injection. ]
Assessment of pain intensity using 10 cm Visual Analogue Scale (VAS pain), 0-10; 0=no pain, 10=the most severe pain.
Symptoms severity and functional impairment of carpal tunnel syndrome (CTS) [ Time Frame: before injection, 4, 12 and 24 weeks post injection. ]
Assessment of CTS symptoms severity and functional impairment using the Boston Carpal Tunnel Questionnaire (BCTQ).
Grip strength [ Time Frame: before injection, 4, 12 and 24 weeks post injection. ]
Assessment of grip strength using the Jamar hydraulic hand dynamometer in kilograms.
Median nerve cross-sectional area (CSA) [ Time Frame: before injection, 4, 12 and 24 weeks post injection. ]
The CSA of the median nerve measured by diagnostic ultrasound at the level of carpal tunnel.
Quality of life (QoL) [ Time Frame: before injection, 4, 12 and 24 weeks post injection. ]
Assessment of QoL using 36-Item Short Form Survey (SF-36).

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information

Ages Eligible for Study:	18 Years to 80 Years (Adult, Older Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

age between 18 and 80 years,
the diagnosis of idiopathic CTS.

Exclusion Criteria:

contraindications for local application of methylprednisolone or 5% dextrose (hypersensitivity to the drug, infection and skin damage at the application site),
previous wrist surgery,
traumatic wrist injury within 2 years,
previous wrist injection within 6 months,
previous physical therapy within 6 months,
history of peripheral traumatic nerve injury in the upper extremity, brachial plexopathy, severe cervical radiculopathy, and thoracic outlet syndrome,
history of diabetes
history of thyroid disease,
history of inflammatory rheumatic disease,
pregnancy,
inability to cooperate with the study protocol.

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06045013

Contacts

Layout table for location contacts

Contact: Igor Begović, MD	+385911748137	igorbegovic2@gmail.com
Contact: Nadica Laktašić Žerjavić, Prof,MD,PhD.	+385915606957	nadica_laktasic@yahoo.com

Locations

Layout table for location information

Croatia
General and Veteran Hospital "Croatian Pride" Knin	Recruiting
Knin, Croatia, 22300
Contact: Igor Begović, MD +385911748137 igorbegovic2@gmail.com
Contact: Marija Anić Matić, Med.techn. +385915257241 glavnasestra@obhpknin.hr
Sub-Investigator: Nadica Laktašić Žerjavić, Prof,MD,PhD.
Sub-Investigator: Milan MIlošević, Prof,MD,PhD.
Sub-Investigator: Željka Pandža, MD
Sub-Investigator: Marija Anić Matić, Med.techn.

Sponsors and Collaborators

General and Veteran Hospital Croatian Pride Knin

Clinical Hospital Centre Zagreb

School of Public Health Andrija Štampar

Investigators

Layout table for investigator information

Principal Investigator:	Igor Begović, MD	General and Veteran Hospital "Croatian Pride" Knin, Croatia

More Information

Additional Information:

Randomization of patients into two groups will be carried out with the help of the above-listed web application. This link exits the ClinicalTrials.gov site

This link exits the ClinicalTrials.gov site

Publications:

Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 May;39(2):175-91. doi: 10.3758/bf03193146.

Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009 Nov;41(4):1149-60. doi: 10.3758/BRM.41.4.1149.

Gao N, Yan L, Ai F, Kang J, Wang L, Weng Y. Comparison of the Short-Term Clinical Effectiveness of 5% Dextrose Water, Platelet-rich Plasma and Corticosteroid Injections for Carpal Tunnel Syndrome: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. Arch Phys Med Rehabil. 2023 May;104(5):799-811. doi: 10.1016/j.apmr.2022.11.009. Epub 2022 Dec 16.

Lin MT, Liao CL, Hsiao MY, Hsueh HW, Chao CC, Wu CH. Volume Matters in Ultrasound-Guided Perineural Dextrose Injection for Carpal Tunnel Syndrome: A Randomized, Double-Blinded, Three-Arm Trial. Front Pharmacol. 2020 Dec 17;11:625830. doi: 10.3389/fphar.2020.625830. eCollection 2020.

Levine DW, Simmons BP, Koris MJ, Daltroy LH, Hohl GG, Fossel AH, Katz JN. A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. J Bone Joint Surg Am. 1993 Nov;75(11):1585-92. doi: 10.2106/00004623-199311000-00002.

Klauser AS, Halpern EJ, De Zordo T, Feuchtner GM, Arora R, Gruber J, Martinoli C, Loscher WN. Carpal tunnel syndrome assessment with US: value of additional cross-sectional area measurements of the median nerve in patients versus healthy volunteers. Radiology. 2009 Jan;250(1):171-7. doi: 10.1148/radiol.2501080397. Epub 2008 Nov 26.

Elnady B, Rageh EM, Ekhouly T, Fathy SM, Alshaar M, Fouda ES, Attar M, Abdelaal AM, El Tantawi A, Algethami MM, Bong D. Diagnostic potential of ultrasound in carpal tunnel syndrome with different etiologies: correlation of sonographic median nerve measures with electrodiagnostic severity. BMC Musculoskelet Disord. 2019 Dec 29;20(1):634. doi: 10.1186/s12891-019-3010-5.

Layout table for additonal information

Responsible Party:	Igor Begović, Physical medicine and rehabilitation specialist, General and Veteran Hospital Croatian Pride Knin
ClinicalTrials.gov Identifier:	NCT06045013
Other Study ID Numbers:	510.01/23-01/76
First Posted:	September 21, 2023 Key Record Dates
Last Update Posted:	September 21, 2023
Last Verified:	September 2023

Layout table for additional information

Studies a U.S. FDA-regulated Drug Product:	Yes
Studies a U.S. FDA-regulated Device Product:	No
Product Manufactured in and Exported from the U.S.:	Yes

Keywords provided by Igor Begović, General and Veteran Hospital Croatian Pride Knin:


Carpal Tunnel Syndrome; Ultrasonography; Injections; Glucose; Glucocorticoids; Pain; Functional Status; Hand Strength, Quality of Life

Additional relevant MeSH terms:

Layout table for MeSH terms

Carpal Tunnel Syndrome Syndrome Disease Pathologic Processes Median Neuropathy Mononeuropathies Peripheral Nervous System Diseases Neuromuscular Diseases Nervous System Diseases Nerve Compression Syndromes Cumulative Trauma Disorders Sprains and Strains Wounds and Injuries Methylprednisolone Methylprednisolone Acetate	Methylprednisolone Hemisuccinate Prednisolone Prednisolone acetate Prednisolone hemisuccinate Prednisolone phosphate Anti-Inflammatory Agents Antiemetics Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Gastrointestinal Agents Glucocorticoids Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Neuroprotective Agents

To Top